ITGAX and gastric cancer: FC/ICFC analysis with fresh gastric cancer samples (FDU‐ZSH EXPC Arm C) also validated that VISTA+ TAMs exhibited significantly higher expression of M2‐like marker CD163 and CD206, as well as M1‐like marker human leukocyte antigen (HLA)‐DR and CD11c (Figure 4G).